Problem statement: Answer the multiple-choice question.
Question: Which compound has a 12.105% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CN(CC(=O)Nc1ccccc1C(F)(F)F)C(=O)COc1cccnc1[N+](=O)[O-]
b) Cc1nnc(NC(=O)CSc2ccc(-c3ccccn3)nn2)s1
Answer: b. Cc1nnc(NC(=O)CSc2ccc(-c3ccccn3)nn2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(NC(=O)CSc2ccc(-c3ccccn3)nn2)s1
Cc1nnc(NC(=O)CSc2ccc(-c3ccccn3)nn2)s1
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-(6-pyridin-2-ylpyridazin-3-yl)sulfanylacetamide